VIA Pharmaceuticals, Inc.
VIAP
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.39% | -21.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.70% | -13.07% | |||
| Operating Income | 26.70% | 13.07% | |||
| Income Before Tax | -16.63% | -1.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.63% | -1.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.63% | -1.23% | |||
| EBIT | 26.70% | 13.07% | |||
| EBITDA | 26.54% | 12.80% | |||
| EPS Basic | -16.22% | -0.88% | |||
| Normalized Basic EPS | -16.38% | -1.09% | |||
| EPS Diluted | -16.22% | -0.88% | |||
| Normalized Diluted EPS | -16.38% | -1.09% | |||
| Average Basic Shares Outstanding | 0.33% | 0.39% | |||
| Average Diluted Shares Outstanding | 0.33% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||